Shanghai Pharmaceuticals (02607): Shangyao Guofeng's Wenjing Tang granules have obtained approval for production

Wisdom Financial APP News, Shanghai Pharmaceuticals (02607) announced that recently, Shanghai Pharmaceuticals Group's subsidiary Qingdao Guofeng Pharmaceuticals Co., Ltd. (hereinafter referred to as "Shanghai Guofeng")'s Wenjing Tang Granules (specification: each bag equivalent to 20g of medicinal slices) received the "Drug Registration Certificate" issued by the National Medical Products Administration (certificate number: 2025S01230), and the drug has been approved for production.